Carmignac Gestion’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
– Sell
-6,116,302
Closed -$352M – 29
2014
Q4
$352M Buy
+6,116,302
New +$341M 3.21% 18

Other funds holding TEVA

Carmignac Gestion's TEVA Position: Q1 2015 in Review

Carmignac Gestion sold out of Teva Pharmaceutical Industries (TEVA) in Q1 2015, closing a stake of 6,116,302 shares — an estimated $352M sold.

Carmignac Gestion first reported a position in TEVA in Q4 2014 and held it in 1 quarter. The position peaked at $352M in Q4 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

  • Carmignac Gestion reported no remaining Teva Pharmaceutical Industries position as of Q1 2015 after selling out during the quarter.
  • Carmignac Gestion sold 6,116,302 Teva Pharmaceutical Industries shares in Q1 2015, an estimated $352M.
  • Carmignac Gestion first reported a position in Teva Pharmaceutical Industries in Q4 2014 and held it in 1 quarter.
  • Carmignac Gestion's Teva Pharmaceutical Industries position peaked at $352M in Q4 2014.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q1 2015.

Based on Carmignac Gestion's 13F filing for Q1 2015, filed 11 May 2015.